SAN ANTONIO, March 18, 2014 /PRNewswire/ -- BiO2 Medical, Inc. is proud to announce the Angel® Catheter Early Feasibility Clinical Study has enrolled its first 3 subjects. Research teams led by Dr. John Holcomb at University of Texas, Houston (Memorial Hermann Hospital)...
Reported by PR Newswire 2 hours ago.
↧